According to this idea, in a PET study on nine schizophrenia patients, 5-week haloperidol therapy caused a significant decrease in DOPA decarboxylase relative activity in the caudate, the putamen, the thalamus, and the orbital and frontal cortices [188]. Here, DDC is linked to schizophrenia.